For a patient with kidney failure, a transplant is usually the best option available. It offers longer survival, a better quality of life and freedom from being tied to a dialysis machine three times a week. In India, though, the hardest part often is not finding a donor or a skilled surgeon. It is paying for the treatment.
What a transplant really costs
A kidney transplant in India typically costs between ₹5 lakh and ₹15 lakh, and complex cases can go up to ₹25 lakh. That is far less than in the West, which is why India attracts patients from abroad. But for most Indian households, it is still a very large amount.
The surgery is only part of the cost. Transplant recipients need immunosuppressant medicines every day for the rest of their lives to stop the body from rejecting the new kidney. Estimates for these range from about ₹8,000 to ₹15,000 a month at the lower end to ₹20,000-30,000 a month at the higher end, depending on the combination of drugs used. Add regular tests, follow-up visits, travel and treatment for infections, and a transplant becomes a long-term financial commitment.
The burden on families
The effect can be severe. A study at PGIMER Chandigarh found that kidney transplantation led to catastrophic out-of-pocket spending and pushed most patients who sought treatment at the public hospital into serious financial trouble. In that study, 78% of patients had no clear plan for paying for immunosuppressants after surgery. Many families end up selling land, taking loans or stopping a child’s education to pay for care.
Late diagnosis makes the problem worse. According to the Indian CKD registry, about 48% of patients are first diagnosed with CKD only at stage 5. By then, families have often already spent their savings on dialysis before a transplant is even considered.
Where help exists
Support is growing, but it is uneven. Ayushman Bharat PM-JAY covers up to ₹5 lakh per eligible family each year, and some sources say it includes living-donor kidney transplants. However, lifelong post-discharge immunosuppressants are often not covered. Employees under ESIC and their dependants can receive a transplant at no cost when referred to an empanelled centre. Several states, including Tamil Nadu, Andhra Pradesh and Goa, have introduced schemes offering free transplant and immunosuppression, while Chief Minister’s relief funds and NGOs help fill some of the remaining gaps.
Public hospitals are also making a major difference. AIIMS reports that a robotic kidney transplant there costs about ₹25,000, compared with several lakhs in corporate hospitals.
Closing the gap
The next step for India is to make transplant support cover the whole journey, not only the operation. Lifelong drug support should be available under public schemes. Generic immunosuppressants that are affordable and quality-assured should be widely available. Stronger deceased-donor programmes would reduce waiting times and the costs of prolonged dialysis. Earlier CKD screening would mean fewer families face a transplant bill after years of expensive treatment.
A transplant gives a patient a new start. It should not leave the family in lasting financial hardship.
